Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

The compound zishenqing formula is effective and safe for treating mild to moderate systemic lupus erythematosus.

Hydroxychloroquine may help delay skin damage in lupus patients.

A woman with both TLE and SLE improved with hydroxychloroquine treatment.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

A 50-year-old woman with breast cancer developed an autoimmune skin disorder, highlighting the need for thorough checks and team-based treatment.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

No treatment showed clear superiority for lichen planopilaris.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

COVID-19 may harm male fertility and damage the reproductive system.

Injectable platelet-rich fibrin may stop hair loss from Discoid lupus erythematosus.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

A woman got a skin rash from taking aceclofenac, which went away after she stopped the drug.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Use antimalarials like hydroxychloroquine for cutaneous lupus, avoid herbal supplements, and focus on lifestyle changes like sun protection.